A citation-based method for searching scientific literature

Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni, Samuel S Freeman, Alexandre Reuben, Paul J Hoover, Alexandra-Chloé Villani, Elena Ivanova, Andrew Portell, Patrick H Lizotte, Amir R Aref, Jean-Pierre Eliane, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, Zachary A Cooper, Cloud P Paweletz, David A Barbie, Anat Stemmer-Rachamimov, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz, Nir Hacohen. Cell 2018
Times Cited: 469



Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, Silvia A Fuertes Marraco, Sandra Calderon-Copete, Daniela Pais Ferreira, Santiago J Carmona, Leonardo Scarpellino, David Gfeller, Sylvain Pradervand, Sanjiv A Luther, Daniel E Speiser, Werner Held. Immunity 2019
Times Cited: 334




List of shared articles



Times cited

PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15.
Kyung Hwan Kim, Hong Kwan Kim, Hyung-Don Kim, Chang Gon Kim, Hoyoung Lee, Ji Won Han, Seong Jin Choi, Seongju Jeong, Minwoo Jeon, Hyunglae Kim,[...]. Cell Mol Immunol 2021
8

Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity.
Qiang Shan, Sheng'en Hu, Xia Chen, Derek B Danahy, Vladimir P Badovinac, Chongzhi Zang, Hai-Hui Xue. Cell Mol Immunol 2021
16

Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy.
Md Amir Hossain, Guilai Liu, Beiying Dai, Yaxuan Si, Qitao Yang, Junaid Wazir, Lutz Birnbaumer, Yong Yang. Med Res Rev 2021
9

Human CXCR5+ PD-1+ CD8 T cells in healthy individuals and patients with hematologic malignancies.
Tom Hofland, Anne W J Martens, Jaco A C van Bruggen, Renate de Boer, Sjoerd Schetters, Ester B M Remmerswaal, Frederike J Bemelman, Mark-David Levin, Adriaan D Bins, Eric Eldering,[...]. Eur J Immunol 2021
1

Tumor-infiltrating lymphocytes in the immunotherapy era.
Sterre T Paijens, Annegé Vledder, Marco de Bruyn, Hans W Nijman. Cell Mol Immunol 2021
27

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.
Faezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin, Hidehiro Yamane, Charles-Antoine Dutertre, Ahad Khalilnezhad, Glennys V Reynoso, Vincent L Coble, Geoffrey M Lynn, Matthew P Mulè,[...]. Nat Immunol 2021
16

Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8+ T cell exhaustion.
Yanmin Cheng, Zhaozhao Shao, Li Chen, Qiaoyu Zheng, Qiqi Zhang, Wenjie Ding, Meng Zhang, Qiongfang Yu, Dian Gao. Immunol Lett 2021
2


Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma.
Miriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, Yue Hou, Abdallah Flaifel, Jean-Christophe Pignon, David A Braun, Megan Wind-Rotolo, Maura A Sticco-Ivins, Paul J Catalano,[...]. Clin Cancer Res 2021
7

Opposing Roles of Type I Interferons in Cancer Immunity.
Giselle M Boukhaled, Shane Harding, David G Brooks. Annu Rev Pathol 2021
3

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Camille-Charlotte Balança, Anna Salvioni, Clara-Maria Scarlata, Marie Michelas, Carlos Martinez-Gomez, Carlos Gomez-Roca, Victor Sarradin, Marie Tosolini, Carine Valle, Frédéric Pont,[...]. JCI Insight 2021
3

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.
Rachel L Rutishauser, Christian Deo T Deguit, Joseph Hiatt, Franziska Blaeschke, Theodore L Roth, Lynn Wang, Kyle A Raymond, Carly E Starke, Joseph C Mudd, Wenxuan Chen,[...]. JCI Insight 2021
11

New cytometry tools for immune monitoring during cancer immunotherapy.
Shomyseh Sanjabi, Sean Lear. Cytometry B Clin Cytom 2021
3

FOXO1 constrains activation and regulates senescence in CD8 T cells.
Arnaud Delpoux, Nimi Marcel, Rodrigo Hess Michelini, Carol D Katayama, Karmel A Allison, Christopher K Glass, Sergio M Quiñones-Parra, Cornelis Murre, Liyen Loh, Katherine Kedzierska,[...]. Cell Rep 2021
3

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
Riyao Yang, Linlin Sun, Ching-Fei Li, Yu-Han Wang, Jun Yao, Hui Li, Meisi Yan, Wei-Chao Chang, Jung-Mao Hsu, Jong-Ho Cha,[...]. Nat Commun 2021
22

Not All Tumor-Infiltrating CD8+ T Cells Are Created Equal.
Werner Held, Daniel E Speiser. Cancer Cell 2021
1

Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
38

BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells.
Chen Yao, Guohua Lou, Hong-Wei Sun, Ziang Zhu, Yi Sun, Zeyu Chen, Daniel Chauss, E Ashley Moseman, Jun Cheng, Marc A D'Antonio,[...]. Nat Immunol 2021
7

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.
Allan Relecom, Maysaloun Merhi, Varghese Inchakalody, Shahab Uddin, Darawan Rinchai, Davide Bedognetti, Said Dermime. J Exp Clin Cancer Res 2021
2

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
Xianwen Ren, Lei Zhang, Yuanyuan Zhang, Ziyi Li, Nathan Siemers, Zemin Zhang. Annu Rev Immunol 2021
9

Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.
Kristen E Pauken, Osmaan Shahid, Kaitlyn A Lagattuta, Kelly M Mahuron, Jacob M Luber, Margaret M Lowe, Linglin Huang, Conor Delaney, Jaclyn M Long, Megan E Fung,[...]. J Exp Med 2021
10

Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.
Wenting Zheng, Jun Wei, Caitlin C Zebley, Lindsay L Jones, Yogesh Dhungana, Yong-Dong Wang, Jayadev Mavuluri, Lingyun Long, Yiping Fan, Ben Youngblood,[...]. Blood 2021
5

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.
Sushil Kumar, Zexian Zeng, Archis Bagati, Rong En Tay, Lionel A Sanz, Stella R Hartono, Yoshinaga Ito, Fieda Abderazzaq, Elodie Hatchi, Peng Jiang,[...]. Cancer Discov 2021
3

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy.
Kim M van Pul, Marieke F Fransen, Rieneke van de Ven, Tanja D de Gruijl. Front Immunol 2021
7

Metabolic Control of Memory T-Cell Generation and Stemness.
Jana L Raynor, Nicole M Chapman, Hongbo Chi. Cold Spring Harb Perspect Biol 2021
0

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Romain Banchereau, Avantika S Chitre, Alexis Scherl, Thomas D Wu, Namrata S Patil, Patricia de Almeida, Edward E Kadel Iii, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi,[...]. J Immunother Cancer 2021
3